Skip to Content
Merck
All Photos(1)

Documents

MABS1352

Sigma-Aldrich

Anti-N3-Phosphohistidine (3-pHis) Antibody, clone SC56-2

clone SC56-2, from rabbit

Synonym(s):

N3-Phosphohistidine

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

rabbit

Quality Level

antibody form

purified antibody

antibody product type

primary antibodies

clone

SC56-2, monoclonal

species reactivity

human, E. coli

species reactivity (predicted by homology)

all

technique(s)

dot blot: suitable
western blot: suitable

isotype

IgG

shipped in

wet ice

target post-translational modification

phosphorylation (N3-pHis)

General description

Phosphorylation plays an important role in regulating protein activities and various cellular signaling events in cells. Limited by the tools available for phosphohistidine (pHis) detection, the majority of studies focus on serine, threonine, and tyrosine phosphorylations. Histidine phosphorylation can occur at either N1 (1-pHis) or N3 (3-pHis) of the imidazole ring. The development of peptides containing stable phosphoryltriazolylalanine analogues of 1-pHis and 3-pHis (1-pTza and 3-pTza) allows the generation of antibodies for studying both histidine N1 and N3 phosphorylations in signaling events. There is growing evidence implicating His kinases in cancer and tumor metastasis and the first metastasis suppressor gene identified is one of the two known mammalian His kinases, Nm23-H1 (also known as NME1, nucleoside diphosphate kinase, or NDPK-A). Nm23-H1/NME1 and the closely related Nm23-H2 (NME2/NDPK-B) catalyze the transfer of phosphate from ATP onto Nucleoside-diphosphates (NDPs) through a 1-pHis enzyme intermediate. Nm23-H1/-H2 also possess His kinase activity, transferring the phosphate from the active site pHis onto a His in a target protein. Metabolic enzymes such as phosphoglycerate mutase (PGAM), succinyl CoA synthase (SCS), and ATP citrate lyase (ACL) also use pHis as an enzyme intermediate. Unlike NME1/2, PGAM uses 3-pHis as an enzyme intermediate. In addition to eukaryotes, histidine phosphorylation is well documented in bacterial “two-component” signaling pathways involved in chemotaxis, although the phosphate is transferred from the pHis formed in the receptor/sensor protein to Asp residues of an acceptor response regulator protein, and the receptor/sensor protein essentially functions as an aspartate kinase.

Specificity

Selectively detects proteins with histidine(s) phosphorylated at N3 of the imidazole ring (3-pHis), but not 1-pHis.
Target modification is not species specific.

Application

Anti-N3-Phosphohistidine (3-pHis) antibody, clone SC56-2 is an isomer-specific monoclonal Ab to specifically detect histidine phosphorylated at position N3. This purified mAb is backed by published data demonstrating performance in Western blotting and dot blot applications.
Dot Blot Analysis: A representative lot detected peptides containing 3-pTza phosphohistidine analogue, but not peptides containing only phosphorylated tyrosine. Clone SC56-2 is most reactive toward 3-pTza peptides based on NM23-H1/NME1 3-pHis118 and PGAM 3-pHis11 sequence, less reactive toward 3-pTza peptides based on ACLY 3-pHis760, histone H4 3-pHis18, or Kca3.1 3-pHis358 sequence, while being least reactive toward GNB1 3-pHis266-based 3-pTza peptide (Fuhs, S.R., et al. (2015). Cell. 162(1):198-210).

Western Blotting Analysis: Clone SC56-2 hybridoma culture supernatant was employed for Western blotting analysis of heat-sensitive histidine N3-phosphorylation (3-pHis) of exogenously expressed human PGAM GST fusion protein in lysates from transformed E. coli (Fuhs, S.R., et al. (2015). Cell. 162(1):198-210).

Note: DO NOT HEAT SAMPLES prior to phosphohistidine detection. Histidine phosphorylation is heat and acid labile. To generate negative control for specificity test, an aliquot of sample can be heated at 95ºC for 10-15 minutes to reverse histidine phosphorylation. Alternatively, an aliquot of sample can be incubated under acidified pH at 37ºC for 15 minutes to reduce histidine phosphorylation. Acidify each 100 µL sample with 25 µL of 1 M HCl before the incubation, then neutralize with 25 µL of 1 M NaOH prior to phosphohistidine detection.

Quality

Evaluated by Western Blotting of PGAM-catalyzed 2,3-DPG degradation reaction.

Western Blotting Analysis: 0.52 µg/mL of this antibody detected recombinant human phosphoglycerate mutase (PGAM) with N3-phosphohistidine (3-pHis) in a 5 µg aliquot of PGAM-catalyzed 2,3-diphosphoglycerate (2,3-DPG) degradation reaction.

Target description

Variable depending on the histidine-phosphorylated proteins.

Physical form

Format: Purified

Other Notes

Concentration: Please refer to lot specific datasheet.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lingyuan Kong et al.
Frontiers in microbiology, 13, 820089-820089 (2022-05-14)
In Streptococcus mutans, we find that the histidine kinase WalK possesses the longest C-terminal tail (CTT) among all 14 TCSs, and this tail plays a key role in the interaction of WalK with its response regulator WalR. We demonstrate that
LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway.
Wang, et al.
Journal of Cancer, 13, 3584-3592 (2022)
Kevin Adam et al.
Methods in molecular biology (Clifton, N.J.), 2077, 209-224 (2019-11-11)
Immunofluorescence (IF) takes advantage of biological and physical mechanisms to identify proteins in cell or tissue samples, exploiting the specificity of antibodies and stimulated fluorescence light emission. Here, we describe an immunofluorescence staining method for the identification of histidine phosphorylated
Jianliang Zhang et al.
Oncogene, 42(6), 449-460 (2022-12-14)
Current clinical therapies targeting receptor tyrosine kinases including focal adhesion kinase (FAK) have had limited or no effect on esophageal squamous cell carcinoma (ESCC). Unlike esophageal adenocarcinomas, ESCC acquire glucose in excess of their anabolic need. We recently reported that
Jianliang Zhang et al.
Cellular and molecular gastroenterology and hepatology, 8(1), 37-60 (2019-03-06)
Most targeted therapies against cancer are designed to block growth factor-stimulated oncogenic growth. However, response rates are low, and resistance to therapy is high. One mechanism might relate to the ability of tumor cells to induce growth factor-independent proliferation (GFIP).

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service